ArticleClinical nephrology. Case studies2026
Idiopathic erythrocytosis as a potential early manifestation with IgA nephropathy: A case report and systematic review.
Article in Clinical nephrology. Case studies, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
IgA nephropathy (IgAN) is the most common primary glomerulonephritis, characterized by mesangial IgA immune complex deposition, potentially leading to chronic kidney disease. Idiopathic erythrocytosis, an unexplained elevation of red blood cell mass, has rarely been reported in association with IgAN. We present a systematic literature review and a new case highlighting the temporal relationship between IgAN and idiopathic erythrocytosis. A PubMed search identified four relevant studies detailing IgAN accompanied by unexplained erythrocytosis. The literature suggests an association predominantly observed in male patients, typically concurrent with or subsequent to an IgAN diagnosis. In our case, however, idiopathic erythrocytosis was detected 2 years prior to the onset of clinical signs of IgAN. The patient, initially treated with phlebotomy, presented 2 years later with significant proteinuria, leading to a renal biopsy confirming IgAN. This temporal progression raises the hypothesis that polymeric IgA1 immune complexes may influence erythropoiesis prior to evident renal involvement. Clinicians should consider underlying glomerular disease in patients with unexplained erythrocytosis, even in the absence of overt renal symptoms.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.